Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Rancho Cordova › NPI 1922615756
Lab

Molecular Matrix, INC.

Molecular Matrix, INC. was paid $150K by Medicaid between Nov 2020 and Nov 2022, across 5 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 71% of everything it billed.

33Billing provider infoMOLECULAR MATRIX, INC.
RANCHO CORDOVA, CA 95670
33aNPI1922615756assigned 09/25/2020
28Total paid$150K
24GClaims8,440
24DCodes billed5
24AFirst – last monthNov 2020 – Nov 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#307 of 561
Median peer was paid$222K
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020141$1K
20215,579$73K
20222,720$77K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 71% 3,021 2,545 $107K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 25% 3,070 2,590 $37K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3.7% 2,264 1,902 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 32 30 $513.10
99072 0% 53 47 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEE, CHARLES (CEO)
Same official

Other billing entities under LEE, CHARLES

Full network →
ProviderLocationPaid
Charles C. Lee DDS, INCEscondido, CA$40K
Cornerstone Health Services LLCTavares, FL$31K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.